Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

•The need for a booster dose remains an open question.•Our results plead for reserving, in the upcoming months, the third dose scheme to individuals who were seronegative prior to vaccination.•Six months after vaccination, a sharper decline in antibody levels is observed in naïve vaccinees compared...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of infection 2021-11, Vol.83 (5), p.559-564
Hauptverfasser:	Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 Antibodies, Viral COVID-19 COVID-19 Vaccines Efficacy Health Personnel Humans Immunogenicity Immunogenicity, Vaccine mRNA-1273 vaccine RNA, Messenger SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!